Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortality

Hypogammaglobulinemia
DOI: 10.1016/j.jaci.2024.10.021 Publication Date: 2024-11-04T08:12:05Z